Manufacturing Solutions

Our team offers the guidance, expertise, technology and manufacturing capacity to help bring your viral vector therapy to market with precision and speed.
Genezen offers a wide range of CDMO services, including process development, cGMP viral vector production, transduced cell manufacturing, and testing.

The Genezen Difference

We are steadfast in our resolve to deliver your project on time and in full. Our focus is providing unwavering support to gene and cell therapy innovators to overcome manufacturing barriers and accelerate clinical drug development programs. Our team leverages in-house capacity, significant technical expertise, and years of viral vector manufacturing experience to deliver comprehensive lentiviral, retroviral, and AAV CDMO services to developers of advanced therapeutics around the globe.

Lentiviral Vector CDMO Services

Retroviral Vector CDMO Services

Cell Therapy CDMO Services

Plasmid Design

Adeno-Associated Viral Vector CDMO Services

Collaborative Project Management

Connecting Great Discoveries with Expert Capabilities

We have the capacity, scalability and reproducibility to accelerate your therapy. Experience the spaces where your therapies are brought to life.

Why work with Genezen?

Our deep expertise, commitment to building trust-based partnerships, state-of-the-art facilities, and talented team enable us to accelerate your AAV, lentiviral, and retroviral vector programs from pre-clinical research to commercial manufacture.

Explore Genezen

Facilities

Our viral vector facility has the capacity and technologies to accelerate your gene or cell therapy to success.

Read more
Quality

We focus on quality to advance your product through clinical milestones as quickly as possible.

Read more
Project Management

Our team is your team; dedicated partnership and flexible support that molds to your needs.

Read more

Meet Our People

Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can’t wait to talk to you about your current challenges and needs.

Steve Favaloro, CEO of Genezen, a viral vector CDMO for cell and gene therapy.

Steve Favaloro

Chairman and Chief Executive Officer
Susan D’Costa, Chief Technical Officer at Genezen, expert in viral vector manufacturing.

Susan D’Costa, PhD

Chief Technical & Commercial Officer
Steve Favaloro, CEO of Genezen, a viral vector CDMO for cell and gene therapy.

Steve Favaloro

Chairman and Chief Executive Officer
Susan D’Costa, Chief Technical Officer at Genezen, expert in viral vector manufacturing.

Susan D’Costa, PhD

Chief Technical & Commercial Officer